WC
BIIB icon

Westhampton Capital’s Biogen BIIB Stock Holding History

Westhampton Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,660
Closed -$471K – 104
2020
Q3 		$471K Hold
1,660
– – 0.38% 68
2020
Q2 		$444K Buy
1,660
+120
+8% +$36.1K 0.39% 70
2020
Q1 		$487K Sell
1,540
-100
-6% -$30.3K 0.51% 59
2019
Q4 		$487K Hold
1,640
– – 0.39% 71
2019
Q3 		$382K Buy
1,640
+390
+31% +$90.8K 0.32% 79
2019
Q2 		$292K Buy
+1,250
New +$289K 0.25% 93

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Westhampton Capital's BIIB Position: Q4 2020 in Review

Westhampton Capital sold out of Biogen (BIIB) in Q4 2020, closing a stake of 1,660 shares — an estimated $471K sold.

Westhampton Capital first reported a position in BIIB in Q2 2019 and held it in 6 quarters. The position peaked at $487K in Q1 2020. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Westhampton Capital reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Westhampton Capital sold 1,660 Biogen shares in Q4 2020, an estimated $471K.
  • Westhampton Capital first reported a position in Biogen in Q2 2019 and held it in 6 quarters.
  • Westhampton Capital's Biogen position peaked at $487K in Q1 2020.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Westhampton Capital's 13F filing for Q4 2020, filed 3 Feb 2021.